Object. In vascular smooth-muscle cells, the Na , and cell volume. Recently, investigations have determined that this exchanger contributes to ischemia and reperfusion injury in coronary circulation. Nonetheless, there is limited information on this glycoprotein in cerebral circulation, especially microcirculation. Thus, the authors in the present study examined the role of NHE in the regulation of cerebral arteriolar tone and its related mechanisms in vitro.
HE NHE was originally described in vesicles isolated from small intestinal and renal brush-border membranes in rats. 24 This transporter has since been identified in the plasma membrane of virtually all eukaryotic cells. An appreciation of the functional relation of NHE has rapidly progressed since this exchanger was cloned in 1989. 34 The presence of a high level of NHE in mammalian cerebrovascular and choroidal tissues has been established both pharmacologically and with the aid of molecular techniques.
14 This exchanger is an approximately 110-kD glycoprotein consisting of 10 to 12 putative transmembranespanning regions followed by a hydrophilic cytoplasmic domain. 33 It catalyzes the electroneutral and reversible exchange of Na ϩ for H ϩ . Thus, NHE regulates [Na ϩ ] i and pH i . Furthermore, NHE is also involved in cell volume control, stimulus response coupling, initiation of cell growth, and cell proliferation. 27, 42 Note that NHE has been reported to be activated by a decrease in [Na ϩ ] i , which is induced by NKA. 20 Additionally, it is known as the major contributor to the Na ϩ influx pathway in VSMCs. 22 Because activation of this transporter mediates Na ϩ influx, both K ϩ and Ca ϩϩ fluxes can also be altered. 42 An increase in [Na ϩ ] i by NHE might produce vasoconstriction attributable to the interrelations of the Na ϩ / Ca ϩϩ exchanger, membrane potential and Ca ϩϩ channels, and numerous Ca ϩϩ -adenosine triphosphatases. 4, 6, 26, 41, 45 Changes in pH i can mediate vasomotor responses through constriction or dilation of the vessels. 43 A contribution of NHE to NO may be exerted by the pH dependence of the enzyme. Fleming, et al., 10 have shown that increasing pH from 5.5 to 7.5 increases NOS activity in cultured endothelial cells. Thus, intracellular alkalinization by NHE may activate NOS and contribute to a dilatory response in vascular smooth muscle. Kitazono, et al., 18 have shown that the activation of NHE may have an important role in NO-dependent dilation of BAs in vivo.
18
The activity of NHE has recently been the focus in many pathogeneses such as ischemia and reperfusion injury in coronary circulation, cardiac hypertrophy, and hypertension. 2, 7, 9, 29, 35, 36 An increased NHE activity caused by intracellular acidosis and a decreased NKA activity caused by energy depletion are responsible for ischemic injury. 13, 25, 31 Therefore, an NHE inhibitor can protect against ischemic injury in the heart and may have clinical benefit in multiple indi- , and cell volume. Recently, investigations have determined that this exchanger contributes to ischemia and reperfusion injury in coronary circulation. Nonetheless, there is limited information on this glycoprotein in cerebral circulation, especially microcirculation. Thus, the authors in the present study examined the role of NHE in the regulation of cerebral arteriolar tone and its related mechanisms in vitro.
Methods. The internal diameter of isolated pressurized intracerebral arterioles in rats was monitored with the aid of a microscope. To examine the basal activity of NHE two kinds of Na 
/H
ϩ exchange inhibitors constricted the arteriole. Subsequent application of NO synthase inhibitor further decreased the diameter of the arterioles. The Na cations connected to cardiac ischemia. Moreover, NHE may contribute to cerebral ischemia. Note that NHE inhibitor prevented the progress of cerebral ischemic damage and edema following MCA occlusion in rats. 39 In a transient occlusion model in rat MCAs, NHE inhibitor also improved endothelial dysfunction induced by ischemic reperfusion injury.
11 Few studies have been undertaken on NHE in the regulation of cerebral vasomotor response, however.
18 To our knowledge, there has been no in vitro study concerning NHE in the regulation of cerebral arteriolar tone.
Thus we initiated the present study to determine the following: basal activity of NHE in the regulation of cerebral arteriolar tone in rats; and contributions of endogenous NO, NKA, and the Na ϩ /Ca ϩϩ exchanger in the NHE-induced vascular response in rat microcirculation in vitro.
Materials and Methods
All experimental protocols were approved by the Animal Ethics Committee of Shinshu University School of Medicine.
Isolated Vessel Preparation
The procedure for vessel preparation has been previously reported.
8 Briefly, male Sprague-Dawley rats (Japan SLC, Hamamatsu, Japan) weighing a mean of 358.4 Ϯ 12.3 g (Ϯ standard error of the mean) were anesthetized with an intraperitoneal injection of pentobarbital sodium (65 mg/kg) and were killed. The brain was removed and transferred to a dissection chamber filled with physiological salt solution (see later). A penetrating arteriole was isolated from the MCA and transferred to a 10-ml vessel chamber containing two glass micropipettes. The arteriole was cannulated using a micropipette and secured with a nylon suture (suture diameter ~10 m; Fig. 1 ). All experiments were conducted without intraluminal flow. Transmural pressure (60 mm Hg) was applied and monitored continuously. The vessel chamber was mounted on the stage of an intravital microscope (Olympus BX51-33; Olympus Co., Tokyo, Japan). The maximal passive internal diameter of the arteriole was determined. The organ bath temperature was then raised from room temperature to the optimal temperature, ranging from 37.5 to 38.5˚C, and kept steady throughout the experiment. The organ bath was continuously circulated by a peristaltic pump (Eyela microtube pump MP-3; Tokyo Rikakikai Co., Ltd., Tokyo, Japan) at a rate of 6 ml/ minute. After an equilibration period, the arteriole constricted spontaneously toward the control basal diameter. Only vessels constricting more than 20% from the maximal passive diameter were acceptable for data analysis.
Vessel Diameter Measurements
The internal diameter of vessels was obtained using an objective lens (10ϫ), a photo-eyepiece lens (5ϫ), and a monochrome chargecoupled device camera (KCB-270A; KOCOM Co., Ltd., Seoul, South Korea) and was displayed on a TV monitor (TM-150S; Nihon Victor, Iwai, Japan). The nature of this internal diameter in response to vasoactive agents was manually measured with a custom-made diameter-detection device, calibrated with a stage micrometer (Nikon Instech Co., Ltd., Kanagawa, Japan), and recorded on a video recorder (HR-S300; Nihon Victor) and a strip chart recorder (VP-6712A; Nihon National Instruments, Tokyo, Japan).
Experimental Protocol
To determine the role of NHE in the regulation of cerebral arteriolar tone in basal conditions, two NHE inhibitors (5-[N,N-hexamethylene]amiloride and FR183998) were evaluated in the first series of experiments.
19,28 Vascular response to 3 mol/L 5-(N,N-hexamethylene)amiloride was obtained, and 0.1 mmol/L L-NMMA, an NOS inhibitor, together with 3 mol/L 5-(N,N-hexamethylene)amiloride were administered to test the contribution of endogenous NO in the NHE regulation of cerebral arteriolar tone.
In the second series of experiments, we tested the contribution of NKA to the NHE inhibitor-induced vascular response. Therefore FR183998 (10 nmol/L) with or without ouabain (0.1 mmol/L) an NKA inhibitor was administered.
In a third series of experiments, the effects of 1 mol/L SEA0400, an Na ϩ /Ca ϩϩ exchange inhibitor, with or without 0.1 mmol/L ouabain, on the FR183998-induced (10 mmol/L) vascular response were analyzed.
Drugs and Solutions
The composition of the physiological salt solution was as follows (in mmol/L): NaCl 144, KCl 3, CaCl 2 2.5, MgSO 4 1.4, pyruvate 2, glucose 5, ethylenediaminetetraacetic acid 0.02, NaH 2 PO 4 1.21, and 3-(N-morpholino)propanesulfonic acid 2. The L-NMMA and 5-(N,N-hexamethylene)amiloride were purchased from Sigma (St. Louis, MO). Fujisawa Pharmaceutical Co., Ltd. (Osaka, Japan) and Taisho Pharmaceutical Co., Ltd. (Tokyo, Japan) kindly provided the FR183998 and SEA0400, respectively.
Statistical Analysis
Only one vessel from each rat brain was studied. Data are presented as the means Ϯ standard error of the mean. To compare the inhibitory effect in NHE inhibitor-induced vasoconstriction, the magnitude of vasomotor responses were expressed as the percentage of change from the control basal diameter (for example, a magnitude equal to the control basal diameter was 0% change). A statistically significant difference was indicated at a probability value less than 0.05 and was determined using repeated-measures analysis of variance together with the Bonferroni multiple comparisons test as the post test or Student t-test (paired or unpaired), as appropriate.
Results
The maximal passive internal diameter was 75.9 Ϯ 2.2 m (22 vessels). All vessels developed spontaneous tone, constricting to a mean control basal diameter of 56 Ϯ 1.8 m.
Both 5-(N,N-hexamethylene)amiloride and FR183998 constricted arterioles in a dose-dependent manner (Fig. 2  left and right) . Extraluminal application of 5-(N,N-hexamethylene)amiloride (3 mol/L) significantly reduced the control basal diameter of cerebral arterioles (four vessels; p Ͻ 0.001, Bonferroni multiple comparisons test; Fig. 3 Although SEA0400 (1 mol/L) had no effect on the control basal diameter, it did inhibit the constriction caused by FR183998 (five vessels; p Ͻ 0.001, Bonferroni multiple comparisons test; Fig. 5 ). In the presence of SEA0400 (1 mol/L), additional treatment with ouabain (0.1 mmol/L) also induced temporary constriction of vessels, but this constriction (7.5 Ϯ 2.4% change of the internal diameter ) was significantly attenuated. The combination of SEA0400 and ouabain totally abolished constriction caused by FR183998 (five vessels; p Ͻ 0.001 compared with control vessels and p Ͻ 0.001 compared with vessels treated with SEA0400, Bonferroni multiple comparisons test).
Discussion
In the present study, we characterized for the first time the basal activity of NHE in the regulation of cerebral arteriolar tone in vitro.
Basal NHE Activity in Intracerebral Arterioles in Rats
In rat intracerebral arterioles, there are many factors controlling the basal tone, such as NO, K ϩ channels, and Ca ϩϩ channels. 12, 16, 40 In the present study, two kinds of NHE inhibitors produced constriction of arterioles. Analysis of these results indicate that NHE is active in the basal state and is responsible for regulating arteriolar tone through its vasodilatory effect. In contrast, Kitazono, et al., 18 reported that NHE inhibitors do not affect the baseline diameter of the rat BA in vivo. This contradistinction may be attributable to the difference in the regulatory mechanism of basal tone in territories of cerebral circulation. Note that there are regional differences in vascular responses between anterior and posterior circulation or between cerebral artery and arteriole according to data from previous studies.
12,44
It has been reported that the activation of NHE causes vasoconstriction in renal resistance vessels and iliac arteries in rats through an increase in [Na ϩ ] i . 41 Our results are in opposition to these data because the basal activity of NHE dilated the intracerebral arterioles.
Role of Endogenous NO in NHE-Induced Vascular Response
Kitazono, et al., 18 reported that intracellular alkalinization produced by NHE may enhance NO production in the rat P. Saesue, et al. BA endothelium and thereby contribute to dilatory responses of the artery in vivo. It may be possible that the basal activity of NHE stimulates production of NO. Nonetheless, our data indicate that endogenous NO production is not altered in the basal activity of NHE given that treatment with an NOS inhibitor following the administration of an NHE inhibitor caused further vasoconstriction.
In preliminary experiments to test the relationship between intracellular acidosis and the vascular response induced by the NHE inhibitor, 5 mmol/L methylammonium chloride, an intracellular alkalinizing agent, 18 did not affect NHE inhibitor-induced vasoconstriction (two vessels; data not shown). This result indicates that intracellular acidosis is not involved in NHE inhibitor-induced vasoconstriction. It is possible that the vasodilatory effect of NHE in the basal state is caused by intracellular alkalinization and subsequent activation of NOS. 10 The relationship between NHE and CO 2 reactivity in the regulation of cerebral arteriolar tone can be explained by the fact that changes in CO 2 content affect pH i . Nonetheless, the alteration of pH i caused by a change in CO 2 content may not be involved in NHE inhibitor-induced vasoconstriction in rat cerebral arterioles. It has been reported in preclinical studies that Na ϩ /H ϩ exchange inhibitors have cardioprotective effects. 2, 7, 9, 29, 35, 36 Recently, it has been reported that inhibition of NHE by FR183998 may have beneficial effects in reducing infarct volume and brain edema during cerebral ischemia in rats.
Role of NKA and Na
17 Horikawa, et al., 11 reported that the protective effect of Na ϩ / H ϩ exchange inhibitor on ischemic brain injury in rats may be at least partially mediated by the prevention of endothelial dysfunction. Nonetheless, the finding in this study that Na ϩ /H ϩ inhibitors induce significant vasoconstriction may raise a question about the effects of these drugs in cerebral microcirculation because significant vasoconstriction may lead to the reduction of cerebral blood flow and worsen ischemic injury. The role of NHE in cerebral ischemia may be different from its role in the normal physiological condition, however, and the exchange inhibitor may have a different effect on cerebral microcirculation. 11, 32 Further studies are required to clarify the role of NHE and its inhibitors in cerebral microcirculation, especially in pathological conditions.
Conclusions
Analysis of data in the present study shows that NHE is active in the basal condition in rat intracerebral arterioles and regulates arteriolar tone through the dilatory response. Endogenous NO is not involved in basal NHE activity. The role of NHE in the regulation of arteriolar tone in rats correlates with the activities of the Na ϩ /Ca ϩϩ exchanger and NKA.
